NSE ScannerOpen the scanner

Cement & Building Materials · Construction Materials · NSE: AMBUJACEM · data 2026-10-31

Ambuja Cements Limited

₹348.05-1.87% on 30 OctHealth: Average 4.4/10
Feb 2026Low ₹341 · High ₹542.45-34.3%

In plain words

Price: 40.9% below its 52-week high of ₹588.75.

Delivery: 38.1% of traded shares were kept for delivery over the last 10 sessions, against 47.6% over the last 60.

Latest results: a net profit of ₹193 cr for the quarter ended Sept 2026.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price
₹348.05
Market cap
₹86,596 cr
P/E
30.8
P/B
1.5
ROE
8.4%
ROCE
4.2%
Debt / equity
0.01
Dividend yield
0.57%
1-year return
-39.4%
52-week high
₹588.75
52-week low
₹341
Operating margin
4.2%

Growth

Revenue (last 12 months)₹39,712 cr
Net profit (last 12 months)₹2,804 cr
Sales growth, 3 years (yearly)9.3%
Profit growth, 3 years (yearly)31.8%

At a glance

Ownership
Strong

Promoters 67.3%, pledged 0.0%, institutions 25.3%.

Valuation
Moderate

P/E 30.8, P/B 1.4, dividend yield 0.6%. Price relative to earnings and book value (low is cheaper, not better).

Efficiency
Weak

ROE 8.4%, ROCE 4.2%, operating margin 4.2%: how much profit it earns on the money it uses.

Financials
Strong

Debt/equity 0.01, Profit growth 31.8% and sales growth 9.3% a year over 3 years.

Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.

Strengths and limitations

Strengths
  • Virtually debt-free (debt/equity 0.1 or less).
  • Profit grew 31.8% a year over 3 years.
Limitations
  • Thin operating margin (4.2%).

Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.

Latest results in brief (Q2 FY27)

AMBUJACEM Q2 FY27 results (consolidated figures, as filed on NSE).

Revenue was ₹9,197 crore, down 3.2% QoQ.

Net profit was ₹193 crore, down 66.6% QoQ.

Operating margin was 13.8%.

EPS was ₹0.78, down 66.4% QoQ.

AMBUJACEM के Q2 FY27 नतीजे (कंसोलिडेटेड आंकड़े, NSE पर दाखिल)।

राजस्व: ₹9,197 करोड़; पिछली तिमाही की तुलना में 3.2% की गिरावट।

शुद्ध मुनाफ़ा: ₹193 करोड़; पिछली तिमाही की तुलना में 66.6% की गिरावट।

ऑपरेटिंग मार्जिन: 13.8%।

EPS: ₹0.78; पिछली तिमाही की तुलना में 66.4% की गिरावट।

AMBUJACEMના Q2 FY27 પરિણામો (કન્સોલિડેટેડ આંકડા, NSE પર ફાઇલ કરેલા).

આવક (રેવન્યુ): ₹9,197 કરોડ; ગયા ક્વાર્ટરની સરખામણીએ 3.2% ઘટાડો.

ચોખ્ખો નફો: ₹193 કરોડ; ગયા ક્વાર્ટરની સરખામણીએ 66.6% ઘટાડો.

ઓપરેટિંગ માર્જિન: 13.8%.

EPS: ₹0.78; ગયા ક્વાર્ટરની સરખામણીએ 66.4% ઘટાડો.

Written from the filed numbers. Not a recommendation.

Smart-money activity

33/100 · Neutral over the last ~60 sessions, data 2026-10-30

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Story so far

2026-10-29: Q2 FY27 results: net profit ₹193 cr2026-07-28: Q1 FY27 results: profit −26.8% YoY2026-06-12: Dividend ₹2 (ex-date)

● Results   ● Dividend

From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.

Quarterly results (consolidated)

QuarterRevenueNet profitProfit YoYOp. marginEPS ₹
Sept 2026₹9,197 cr₹193 cr—13.8%0.78
Jun 2026₹9,500 cr₹577 cr-26.8%16.7%2.32
Dec 2025₹10,277 cr₹204 cr—13.2%0.82
Jun 2025₹10,289 cr₹788 cr—19.1%3.2

Shareholding trend

HolderJun 2026
Promoters67.33%
Foreign institutions (FII)5.63%
Domestic institutions (DII)19.65%
Mutual funds9.12%
Retail investors4.93%
Number of shareholders6,74,206

Common questions

What was Ambuja Cements Limited's latest quarterly profit?

Ambuja Cements Limited reported a net profit of ₹193 cr for the quarter ended Sept 2026, on revenue of ₹9,197 cr.

How much do promoters hold in Ambuja Cements Limited?

Promoters held 67.33% of Ambuja Cements Limited at the end of Jun 2026, with 0.00% of promoter shares pledged.

Is Ambuja Cements Limited debt-free?

Its latest reported debt-to-equity ratio is 0.01, which is very low.

What is Ambuja Cements Limited's P/E ratio?

About 30.8, based on the last 12 months' earnings and a price of ₹348.05 (data 2026-10-31).

What is the 52-week high and low of Ambuja Cements Limited?

The 52-week high is ₹588.75 and the 52-week low is ₹341.

Mutual funds holding Ambuja Cements Limited

From the monthly portfolios of the fund houses the site reads, as of 2026-09-30. 35 schemes holding about ₹2,270 cr; funds that hold it outside their top holdings may not be listed.

SchemeFund house% of fundValue
Mirae Asset Large Cap FundMirae Asset Mutual Fund0.87%₹310 cr
Mirae Asset ELSS Tax Saver FundMirae Asset Mutual Fund0.94%₹232 cr
ADITYA BIRLA SUN LIFE ELSS TAX SAVER FUNDAditya Birla Sun Life Mutual Fund1.68%₹228 cr
ADITYA BIRLA SUN LIFE LARGE CAP FUNDAditya Birla Sun Life Mutual Fund0.68%₹190 cr
NIPPON INDIA POWER & INFRA FUNDNippon India Mutual Fund1.99%₹157 cr
Nippon India ELSS Tax Saver FundNippon India Mutual Fund0.72%₹102 cr
ADITYA BIRLA SUN LIFE VALUE FUNDAditya Birla Sun Life Mutual Fund1.42%₹95 cr
Mirae Asset Aggressive Hybrid FundMirae Asset Mutual Fund1.02%₹94 cr
NIPPON INDIA ETF NIFTY NEXT 50 JUNIOR BEESNippon India Mutual Fund0.95%₹82 cr
ADITYA BIRLA SUN LIFE MNC FUNDAditya Birla Sun Life Mutual Fund1.61%₹49 cr
ADITYA BIRLA SUN LIFE AGGRESSIVE HYBRID FUNDAditya Birla Sun Life Mutual Fund0.60%₹41 cr
NIPPON INDIA RETIREMENT FUND - WEALTH CREATION SCHEMENippon India Mutual Fund1.32%₹39 cr
ADITYA BIRLA SUN LIFE CONGLOMERATE FUNDAditya Birla Sun Life Mutual Fund2.25%₹34 cr
SBI Nifty Next 50 ETFSBI Mutual Fund0.95%₹28 cr
SBI Nifty Next 50 Index FundSBI Mutual Fund0.96%₹22 cr

Compared with similar companies

CompanyPriceMarket capP/EP/BROEROCEDebt/eq.1-yr return
Ambuja Cements Limited₹348.05₹86,596 cr30.81.58.4%4.2%0.01-39.4%
UltraTech Cement Limited₹11,045₹3,25,320 cr36.94.411.1%11%0.31-8.3%
Grasim Industries Ltd.₹2,981.4₹2,01,687 cr35.6—4.9%8.2%2.2+0.7%
Shree Cement Limited₹22,995₹83,235 cr52.43.57.8%7.5%0.08-21.3%
J.K. Cement Ltd.₹4,785.5₹36,854 cr38.6515.1%11.2%0.88-24.6%
Dalmia Bharat Ltd.₹1,326.2₹24,847 cr50.81.46.4%5.7%0.41-38.2%

Compare AMBUJACEM with ULTRACEMCO in detail →

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open AMBUJACEM in NSE Scanner →
Share on WhatsAppShare on Telegram